<DOC>
	<DOCNO>NCT02742233</DOCNO>
	<brief_summary>To investigate effect Dipeptidyl Peptidase 4 Inhibition wound heal patient diabetic foot ulcer , investigator randomly divide participant two group : saxagliptin regular treatment groupï¼Œplacebo regular treatment group . The clinical data collect give time point . This study aim observe potential protective effect DPP4i diabetic ulcer .</brief_summary>
	<brief_title>Dipeptidyl Peptidase 4 Inhibition Facilitate Healing Diabetic Ulcers</brief_title>
	<detailed_description>Groups : Diabetic ulcer , saxagliptin + Regular treatment . Diabetic ulcer , placebo + Regular treatment . Time Point : Initial treatment ; Post-treatment ( 1w ) ; Post-treatment ( 2w ) ; Post-treatment ( 4w ) ; Completely heal .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>Diagnosis diabetes mellitus accord World Health Organization criterion ( treatment insulin oral hypoglycemic agent , twice random glucose measurement major 200 mg/dl , fast glucose major 140 mg/dl ) Ulcer locate legs foot , stage III IV ( Wagner Classification System ) The subject agree comply study protocol requirement follow visit requirement . Uncontrolled diabetes Ulcer infection Nondiabetic ulcer Orthopedic neuromuscular pathologic condition</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Wound Healing</keyword>
	<keyword>Dipeptidyl Peptidase 4 Inhibition</keyword>
</DOC>